Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0090-6980(74)80133-4 | DOI Listing |
NPJ Parkinsons Dis
December 2024
Roche Pharma Research and Early Development (pRED), Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
In a recent Viewpoint article (. 2024;81:789‒90), Okubadejo et al. raised concerns regarding two recent proposals for biological definitions and staging systems for synucleinopathies (the Neuronal Synuclein Disease Integrated Staging System and SynNeurGe system).
View Article and Find Full Text PDFBlood Cancer J
May 2023
A.O.U. Policlinico Umberto I, Università degli Studi di Roma "La Sapienza", Rome, Italy.
Ann Rheum Dis
August 2022
The Feinstein Institute for Medical Research, Manhasset, New York, USA
FEBS Lett
June 2016
Molecular Microbiology and Biotechnology, Institute of Biology Leiden, Leiden University, The Netherlands.
We identified the d-galacturonic acid (GA)-responsive transcriptional activator GaaR of the saprotrophic fungus, Aspergillus niger, which was found to be essential for growth on GA and polygalacturonic acid (PGA). Growth of the ΔgaaR strain was reduced on complex pectins. Genome-wide expression analysis showed that GaaR is required for the expression of genes necessary to release GA from PGA and more complex pectins, to transport GA into the cell, and to induce the GA catabolic pathway.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!